Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mead Johnson Hopes To Milk JV For Latin American Growth

This article was originally published in The Tan Sheet

Executive Summary

An 80-20 joint venture with dairy producer SanCor likely will help Mead Johnson cement its footprint in Argentina and other Latin American countries. Meanwhile, the pediatric nutritionals firm maintains muted expectations for the U.S. in 2012.

You may also be interested in...



Mead Johnson Milks Growth Of Emerging Market Middle Class

Mead Johnson sees growth in emerging markets largely because per-birth consumption of infant formula is well below developed regions. The firm invests nearly $100 million in research to provide the pediatric nutritionals innovation sought by parents, VP of Investor Relations Kathy Ann MacDonald says.

Mead Johnson Milks Growth Of Emerging Market Middle Class

Mead Johnson sees growth in emerging markets largely because per-birth consumption of infant formula is well below developed regions. The firm invests nearly $100 million in research to provide the pediatric nutritionals innovation sought by parents, VP of Investor Relations Kathy Ann MacDonald says.

Mead Johnson Milks Growth Of Emerging Markets’ Middle Class

Mead Johnson sees growth in emerging markets largely because per-birth consumption of infant formula is well below developed regions. The firm invests nearly $100 million in research to provide the pediatric nutritionals innovation sought by parents, VP of Investor Relations Kathy Ann MacDonald says.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS105585

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel